Follow Us
HIV Treatment and Medical Care

Videx (Didanosine, ddI)

The Latest

An Overview of Videx (Didanosine) Img

An Overview of Videx (Didanosine)

Brand Name: Videx EC, Videx Other Names: ddI, ddl EC, delayed-release didanosine, dideoxyinosine, enteric-coated didanosine Drug Class: Nucleoside Reverse Transcriptase Inhibitors

Didanosine (Videx, ddI) Img

Didanosine (Videx, ddI)

Table of Contents

What Is Didanosine? Who Should Take Didanosine? What About Drug Resistance? How Is Didanosine Taken? What Are the Side Effects? How Does Didanosine React With Other Drugs?

What Is Didanosine?

ddI (Videx) is a drug used ...

Promo Image

Videx EC

Brand name: Videx EC and Videx

Generic name: didanosine, or ddI

Class: Nucleoside reverse transcriptase inhibitor (nucleoside, NRTI, or nuke)

Manufacturer: Bristol-Myers Squibb,, (800) 321-1335

AWP: $425.00/month for Videx EC 400 mg c...

AIDS Activist Allen Huff Dies of an HIV Drug Side Effect: A Blog Entry by Nelson Vergel Img

AIDS Activist Allen Huff Dies of an HIV Drug Side Effect: A Blog Entry by Nelson Vergel

My friend, Allen Huff, died on Friday. He battled portal hypertension caused by Videx (DDI) and was not a candidate for surgery to repair the damage caused by that drug (read the FDA report that mentions the label change for the drug just last year: ...

Promo Image

Emtriva + Reyataz + Videx Not as Effective as Combivir + Sustiva in First-Line Therapy, Study Finds

"In the AIDS field, we often talk about how things were 20 years ago when widespread fear prevailed and knowledge of the virus was minimal," John Samuels -- administrative director of AIDS services at Beth Israel Medical Center -- writes in a New Yor...

Promo Image

Videx (Didanosine)

Videx tablets (above left) are round and off-white to pale yellow-orange, with "Videx" on one side and the tablet strength on the other side. Videx EC (above right) is an enteric-coated, white capsule labeled with "BMS 400 mg" and "6674" in red. The ...

Promo Image

FDA Approves Videx EC and Trizivir

Videx EC

A new formulation of the nucleoside reverse transcriptase inhibitor (NRTI) Videx was recently approved by the U.S. Food and Drug Administration (FDA). Videx EC is a new formulation of the anti-HIV medication ddI, (also known as didanosine a...

Promo Image

Enteric-coated ddI Approved: FDA Letter

On October 31, 2000 the FDA approved a new once-daily formulation of ddI which is easier and less complicated to take, avoids certain drug interactions, and may reduce diarrhea or other gastrointestinal side effects. But the overall safety and effic...

Promo Image

ddI, d4T and Hydroxyurea Side Effect Warning!

The FDA recently issued a warning that when using ddI (didanosine, Videx), some people may develop pancreatitis (a potentially life-threatening inflammation of the pancreas). An early symptom includes severe abdominal pain, which should be carefully ...

Promo Image

Improved Tolerability and Adherence With Reduced Mass Didanosine Tablets in HIV-1 Infected Adults Receiving Highly Active Antiretroviral Therapy

Authored by A. Harling, S. Doshi, H. Leake, et al.

Abstract 503


Recently , the FDA in the US has approved a new formulation of ddI (also known as Videx or didanosine). While the drug can be very successful, it is one of the antivirals t...